Maddrey WC. Hepatitis B – an important public health issue. Cl<strong>in</strong> Lab 2001; 47:51-55.Malamitsi-Puchner A, Papacharitonos S, Sotos D, Tzala L, Psichogiou M, Hatzakis A,Evangelopoulou A, Michalas S. Prevalence study <strong>of</strong> different <strong>hepatitis</strong> markers among pregnantAlbanian refugees <strong>in</strong> Greece. Eur J Epidemiol 1996; 12:297-301.Marschall T, Krämer A, Prüfer-Krämer L, Mikolajczyk R, Kretzschmar M. Does migration fromhigh <strong>and</strong> <strong>in</strong>termediate endemic regions <strong>in</strong>crease the prevalence <strong>of</strong> <strong>hepatitis</strong> B <strong>in</strong>fection <strong>in</strong>Germany? Dtsch Med Wochenschr 2005; 130:2753-2758. [Article <strong>in</strong> German]Masia G, M<strong>in</strong>erba L, Aresu C, Brundu A, Campanelli C, Pedron M, Rossi G, Tirotto MT, CoppolaRC. Adherence to the screen<strong>in</strong>g program for HBV <strong>in</strong>fection <strong>in</strong> pregnant women <strong>and</strong> application<strong>of</strong> the immunoprophylaxis protocol <strong>in</strong> babies born to HBV carrier women. Ig Sanita Pubbl 2003;59:373-382. [Article <strong>in</strong> Italian]Mast EE, Mahoney FJ, Alter MJ, Margolis HS. Progress toward elim<strong>in</strong>ation <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong><strong>transmission</strong> <strong>in</strong> the United States. Vacc<strong>in</strong>e 1998; 16(Suppl):S48-S51.Mast EE, Margolis HS, Fiore AE, Br<strong>in</strong>k EW, Goldste<strong>in</strong> ST, Wang SA, Moyer LA, Bell BP, AlterMJ, on behalf <strong>of</strong> the Advisory Committee on Immunization Practices (ACIP). A comprehensiveimmunization strategy to elim<strong>in</strong>ate <strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong> <strong>in</strong>fection <strong>in</strong> the UnitedStates: recommendations <strong>of</strong> the Advisory Committee on Immunization Practices (ACIP) part 1:immunization <strong>of</strong> <strong>in</strong>fants, children, <strong>and</strong> adolescents. MMWR Recomm Rep 2005; 54(RR-16):1-23.http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a1.htm?s_cid=rr5416a1_e [AccessedMarch 2006][Errata: 2006; 54(RR-16). MMWR 2006; 55(06):158-159.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5506a6.htm] [Accessed March 2006]McIntosh ED. Paediatric <strong>in</strong>fections: prevention <strong>of</strong> <strong>transmission</strong> <strong>and</strong> disease – implications foradults. Vacc<strong>in</strong>e 2005; 23:2087-2089.Mikhailov MI, Gomberg MA, Dolzhanskaya NA, Koubanova AA. Significance <strong>of</strong> sexual route <strong>of</strong><strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> B <strong>and</strong> C <strong>in</strong> Russia. Int J STD AIDS 2002; 13(Suppl 2):9-11.Mittal SK, Rao S, Rastogi A, Aggarwal V, Kumari S. Hepatitis B – potential <strong>of</strong> <strong>per<strong>in</strong>atal</strong><strong>transmission</strong> <strong>in</strong> India. Trop Gastroenterol 1996; 17:190-192.Mok J, Pembrey L, Tovo PA, Newell ML, <strong>and</strong> the European Paediatric Hepatitis C VirusNetwork. When does mother to child <strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> C <strong>virus</strong> occur? Arch Dis ChildFetal Neonatal Ed 2005; 90:F156-F160.Mondelli MU. Neonatal blood microtransfusions <strong>and</strong> <strong>hepatitis</strong> C <strong>virus</strong> <strong>in</strong>fection. Lancet 2001;357:1363.Moskovskaia IA, Kuz<strong>in</strong>a LE, Anichk<strong>in</strong>a TV, Alesh<strong>in</strong> IK, Ul'ianova LA, Kuz<strong>in</strong> SN. Experiencewith vacc<strong>in</strong>e prophylaxis <strong>of</strong> <strong>hepatitis</strong> B among different groups <strong>of</strong> children. Zh MikrobiolEpidemiol Immunobiol 2003; 2:42-46. [Article <strong>in</strong> Russian]Murhekar MV, Murhekar KM, Arankalle VA, Sehgal SC. Epidemiology <strong>of</strong> <strong>hepatitis</strong> B <strong>in</strong>fectionamong the Nicobarese – a mongoloid tribe <strong>of</strong> the Andaman <strong>and</strong> Nicobar Isl<strong>and</strong>s, India.Epidemiol Infect 2002; 128:465-471.Nacro B, Dao B, Dahourou H. HBs antigen <strong>in</strong> children with suspicion <strong>of</strong> HIV <strong>in</strong>fection. J TropPediatr 2001; 47:303-304.Netesova IG, Swenson PD, Osipova LP, Kiselev NN, Posukh OL, Cherepanova NS, KazakovtsevaMA, Kash<strong>in</strong>skaia IuO, Netesov SV. Hepatitis B markers <strong>in</strong> southern Altai <strong>in</strong>habitants <strong>of</strong> thevillage <strong>of</strong> Mendur-Sokkon (the Republic <strong>of</strong> Altai). HBsAg subtyp<strong>in</strong>g <strong>in</strong> <strong>hepatitis</strong> B <strong>virus</strong> isolateswith monoclonal antibodies. Zh Mikrobiol Epidemiol Immunobiol 2001; 2:29-33. [Article <strong>in</strong>Russian]Noto H, Terao T, Ryou S, Hirose Y, Yoshida T, Ookubo H, Mito H, Yoshizawa H, for the SpecialCommittee for prevent<strong>in</strong>g <strong>hepatitis</strong> B <strong>in</strong> Shizuoka. Comb<strong>in</strong>ed passive <strong>and</strong> activeimmunoprophylaxis for prevent<strong>in</strong>g <strong>per<strong>in</strong>atal</strong> <strong>transmission</strong> <strong>of</strong> the <strong>hepatitis</strong> B <strong>virus</strong> carrier state <strong>in</strong>Shizuoka, Japan dur<strong>in</strong>g 1980-1994. J Gastroenterol Hepatol 2003; 18:943-949.Ohba K, Mizokami M, Kato T, Ueda R, Gurtsenvitch V, Senyuta N, Syrtsev A, Zoya K,Yamashita M, Hayami M. Seroprevalence <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong>, <strong>hepatitis</strong> C <strong>virus</strong> <strong>and</strong> GB <strong>virus</strong>-C<strong>in</strong>fections <strong>in</strong> Siberia. Epidemiol Infect 1999; 122:139-143.54
Onishchenko GG. Incidence <strong>of</strong> <strong>in</strong>fectious <strong>hepatitis</strong> <strong>in</strong> the Russian Federation <strong>and</strong> sociomedicalmeasures to prevent its prevalence. Vestn Ross Akad Med Nauk 2001; 8:31-34. [Article <strong>in</strong>Russian]Oram RJ, Daum RS, Seal JB, Lauderdale DS. Impact <strong>of</strong> recommendations to suspend the birthdose <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong> vacc<strong>in</strong>e. JAMA 2001; 285:1874-1879.Ordog K, Szendroi A, Szarka K, Kugler Z, Csire M, Kapus<strong>in</strong>szky B, Xie J, Csizmadia K, BrojnasJ, Rusvai E, Tempfli A, Berencsi G. Per<strong>in</strong>atal <strong>and</strong> <strong>in</strong>trafamily <strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong> <strong>in</strong>three generations <strong>of</strong> a low-prevalence population. J Med Virol 2003; 70:194-204.Orlova OA, Karazhas NV, Rusakova EV. HIV <strong>in</strong>fection <strong>in</strong> pregnant women <strong>in</strong> Chelyab<strong>in</strong>sk. ZhMikrobiol Epidemiol Immunobiol 2005; 1:73-74. [Article <strong>in</strong> Russian]Poovorawan Y, Sripattanawat R, Theamboonlers A, Chongsrisawat V, Nuchprayoon I.Hepatocellular carc<strong>in</strong>oma: significance <strong>of</strong> HBV vertical <strong>transmission</strong>. Asian Pac J AllergyImmunol 1998; 16:93-103.Poovorawan Y, Theamboonlers A, Hirsch P, Vimolket T, S<strong>in</strong>laparatsamee S, Chaiear K,Siraprapasiri T, Khwanjaipanich S, Owatanapanich S, Chunsuttiwat S. Persistence <strong>of</strong> antibodiesto the surface antigen <strong>of</strong> the <strong>hepatitis</strong> B <strong>virus</strong> (anti-HBs) <strong>in</strong> children subjected to the Exp<strong>and</strong>edProgramme on Immunization (EPI), <strong>in</strong>clud<strong>in</strong>g <strong>hepatitis</strong>-B vacc<strong>in</strong>e, <strong>in</strong> Thail<strong>and</strong>. Ann Trop MedParasitol 2000;94:615-621.Pujol FH, Rodriguez I, Mart<strong>in</strong>ez N, Borberg C, Favorov MO, Fields HA, Lipr<strong>and</strong>i F. Viral<strong>hepatitis</strong> serological markers among pregnant women <strong>in</strong> Caracas, Venezuela: implication for<strong>per<strong>in</strong>atal</strong> <strong>transmission</strong> <strong>of</strong> <strong>hepatitis</strong> B <strong>and</strong> C. G E N 1994; 48:25-28.Rakhimov RA. The spread <strong>of</strong> HB <strong>virus</strong> <strong>in</strong>fection <strong>in</strong> familial foci <strong>in</strong> a territory hyperendemic for<strong>hepatitis</strong> B. Zh Mikrobiol Epidemiol Immunobiol 1990; 7:27-31. [Article <strong>in</strong> Russian]Ramsay M, Gay N, Balogun K, Coll<strong>in</strong>s M. Control <strong>of</strong> <strong>hepatitis</strong> B <strong>in</strong> the United K<strong>in</strong>gdom. Vacc<strong>in</strong>e1998; 16(Suppl):S52-S55.Rashidova RA, Iuldashev KKh, Valiev AG. Epidemiological characterisation <strong>of</strong> acute <strong>and</strong> chronic<strong>hepatitis</strong> B <strong>in</strong> Uzbekistan. Zh Mikrobiol Epidemiol Immunobiol 2003; 1:23-26. [Article <strong>in</strong>Russian]Reshetnikov OV, Khryan<strong>in</strong> AA, Te<strong>in</strong><strong>in</strong>a TR, Krivenchuk NA, Zim<strong>in</strong>a IY. Hepatitis B <strong>and</strong> Cseroprevalence <strong>in</strong> Novosibirsk, western Siberia. Sex Transm Infect 2001; 77:463.Roussos A, Goritsas C, Pappas T, Spanaki M, Papadaki P, Ferti A. Prevalence <strong>of</strong> <strong>hepatitis</strong> B <strong>and</strong> Cmarkers among refugees <strong>in</strong> Athens. World J Gastroenterol 2003; 9:993-995.Ruzibakiev R, Kato H, Ueda R, Yuldasheva N, Hegay T, Avazova D, Kurbanov F, Zalalieva M,Tuichiev L, Achundjanov B, Mizokami M. Risk factors <strong>and</strong> seroprevalence <strong>of</strong> <strong>hepatitis</strong> B <strong>virus</strong>,<strong>hepatitis</strong> C <strong>virus</strong>, <strong>and</strong> human immunodeficiency <strong>virus</strong> <strong>in</strong>fection <strong>in</strong> Uzbekistan. Intervirology2001; 44:327-332.Sempr<strong>in</strong>i AE, Savasi V, Holl<strong>and</strong>er L, Tanzi E. Mother-to-child HCV <strong>transmission</strong>. Lancet 2001;357:141.Sempr<strong>in</strong>i AE, Zanetti AR. Hepatitis C <strong>and</strong> pregnancy. In: Liang TJ, Ho<strong>of</strong>nagle JH, Eds. HepatitisC. Biomedical Research Reports, Volume 2 (Gall<strong>in</strong> JI, Fauci AS, Series Eds). Academic Press,2000.Shag<strong>in</strong>ian VR. The <strong>per<strong>in</strong>atal</strong> <strong>in</strong>fection problem <strong>in</strong> viral hepatitides. Mikrobiol Z 1999; 61:71-79.[Article <strong>in</strong> Russian]Shakhgil'dian IV, Farber NA, Kuz<strong>in</strong> SN, Cheshik SG, Drobeniuk ZhA, Mikhailov MI,Khukhlovich PA, Gorbunov MA, Ikoev VN, Golosova TV, et al. Per<strong>in</strong>atal <strong>in</strong>fection with<strong>hepatitis</strong> B <strong>virus</strong> <strong>and</strong> the problem <strong>of</strong> its specific prevention. Vestn Akad Med Nauk SSSR 1990;7:29-32. [Article <strong>in</strong> Russian]Shakhgil'dian IV, Onishchenko GG, Khukhlovich PA, Anan'ev VA, Kuz<strong>in</strong> SN, Klimenko SM.Study results <strong>and</strong> the unresolved problems <strong>in</strong> the epidemiology <strong>and</strong> prevention <strong>of</strong> parenteral viral<strong>hepatitis</strong> <strong>in</strong> Russia. Zh Mikrobiol Epidemiol Immunobiol 1994; 5:26-32. [Article <strong>in</strong> Russian]Shrestha SM, Takeda N, Tsuda F, Okamoto H, Shrestha S, Shrestha VM. High prevalence <strong>of</strong><strong>hepatitis</strong> B <strong>virus</strong> <strong>in</strong>fection amongst Tibetans <strong>in</strong> Nepal. Trop Gastroenterol 2002; 23:63-65.Sterneck M, Kal<strong>in</strong><strong>in</strong>a T, Otto S, Günther S, Fischer L, Burdelski M, Greten H, Brölsch CE, WillH. Neonatal fulm<strong>in</strong>ant <strong>hepatitis</strong> B: structural <strong>and</strong> functional analysis <strong>of</strong> complete <strong>hepatitis</strong> B<strong>virus</strong> genomes from mother <strong>and</strong> <strong>in</strong>fant. J Infect Dis 1998; 177:1378-1381.55
- Page 1 and 2:
Pre-meeting documentPrevention and
- Page 3 and 4: Part I Prevention and control of pe
- Page 5 and 6: prevalence was significantly higher
- Page 7 and 8: clusters (obstetrics wards/hospital
- Page 9 and 10: Boxall E. Screening of pregnant wom
- Page 11 and 12: Chang MH, Hsu HY, Huang LM, Lee PI,
- Page 13 and 14: of infection in infants and childre
- Page 15 and 16: Eriksen EM, Perlman JA, Miller A, M
- Page 17 and 18: liver enzyme abnormalities than wer
- Page 19 and 20: health care, is feasible and achiev
- Page 21 and 22: HBsAg and anti-HBs in 4.5%. In the
- Page 23 and 24: immunoprophylaxis. Reflecting effec
- Page 25 and 26: Levin CE, Nelson CM, Widjaya A, Mon
- Page 27 and 28: Delaying vaccination of premature i
- Page 29 and 30: diagnosis. In the past, the inciden
- Page 31 and 32: shows that the prevalence of HBV in
- Page 33 and 34: Niu MT, Targonski PV, Stoll BJ, Alb
- Page 35 and 36: Ranger-Rogez S, Alain S, Denis F. H
- Page 37 and 38: vaccinees) and low reactogenicity o
- Page 39 and 40: single ELISA test is about Rs40. At
- Page 41 and 42: newborns with surface antigenemia,
- Page 43 and 44: Wang Z, Zhang J, Yang H, Li X, Wen
- Page 45 and 46: of hepatitis B vaccine. This study
- Page 47 and 48: transmission has been estimated at
- Page 49 and 50: at birth and 2 weeks after birth, f
- Page 51 and 52: Chubinishvili OV, Mikhailov MI, Sak
- Page 53: Jensen L, Heilmann C, Smith E, Want
- Page 57: Zanetti A, Tanzi E, Semprini AE. He